2-hydroxyamide derivatives are produced based on the kineticresolution of racemic 2-hydroxyamides with a diphenylacetyl component and (R)-benzotetramisole ((R)-BTM), a chiral acyl-transfer catalyst, via asymmetric esterification and acylation. It was revealed that a tertiary amide can be used with this novel protocol to achieve high selectivity (22 examples; s-value reaching over 250). The resulting chiral
[EN] PURINE COMPOUNDS FOR TREATING AUTOIMMUNE AND DEMYELINATING DISEASES<br/>[FR] COMPOSÉS DE PURINE POUR LE TRAITEMENT DE MALADIES AUTO-IMMUNES ET DÉMYÉLINISANTES
申请人:DCAM PHARMA INC
公开号:WO2011106168A1
公开(公告)日:2011-09-01
A compound of Formula (I), or a pharmaceutically acceptable salt thereof. Values and preferred values of variables A1, A2 and R1 are provided herein.
化合物I的公式,或其药学上可接受的盐。此处提供变量A1,A2和R1的值和首选值。
COMPOSES DE TYPE ETHER-AMIDE ET UTILISATIONS
申请人:Rhodia Operations
公开号:EP2491008A1
公开(公告)日:2012-08-29
US8981150B2
申请人:——
公开号:US8981150B2
公开(公告)日:2015-03-17
[EN] ETHER-AMIDE COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSES DE TYPE ETHER-AMIDE ET UTILISATIONS
申请人:RHODIA OPERATIONS
公开号:WO2011048314A1
公开(公告)日:2011-04-28
La présente invention a pour objet de nouveaux composés, de type éther-amide. Elle a également pour objet des utilisations de tels composés, notamment comme solvants, par exemple dans des formulations phytosanitaires.